The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pressurized Metered-dose Inhaler Market Research Report 2024
Synopsis
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
The global Pressurized Metered-dose Inhaler market was valued at US$ 6030.8 million in 2023 and is anticipated to reach US$ 7418.6 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Pressurized Metered-dose Inhaler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pressurized Metered-dose Inhaler.
Report Scope
The Pressurized Metered-dose Inhaler market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pressurized Metered-dose Inhaler market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pressurized Metered-dose Inhaler manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Glenmark Pharmaceuticals(India)
Novartis International AG(Switzerland)
Propeller Health(USA)
AstraZeneca Plc(Sweden)
Philips Respironics(Netherlands)
Teva Pharmaceutical Industries(Israel)
Opko Health(USA)
Merck(USA)
BioCare Group(Malaysia)
Segment by Type
Single-dose Inhalers
Multi-dose Inhalers
Segment by Application
Hospitals
Ambulatory Surgery Centres
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pressurized Metered-dose Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pressurized Metered-dose Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
The global Pressurized Metered-dose Inhaler market was valued at US$ 6030.8 million in 2023 and is anticipated to reach US$ 7418.6 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Pressurized Metered-dose Inhaler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pressurized Metered-dose Inhaler.
Report Scope
The Pressurized Metered-dose Inhaler market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pressurized Metered-dose Inhaler market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pressurized Metered-dose Inhaler manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Glenmark Pharmaceuticals(India)
Novartis International AG(Switzerland)
Propeller Health(USA)
AstraZeneca Plc(Sweden)
Philips Respironics(Netherlands)
Teva Pharmaceutical Industries(Israel)
Opko Health(USA)
Merck(USA)
BioCare Group(Malaysia)
Segment by Type
Single-dose Inhalers
Multi-dose Inhalers
Segment by Application
Hospitals
Ambulatory Surgery Centres
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pressurized Metered-dose Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pressurized Metered-dose Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pressurized Metered-dose Inhaler Market Overview
1.1 Product Overview and Scope of Pressurized Metered-dose Inhaler
1.2 Pressurized Metered-dose Inhaler Segment by Type
1.2.1 Global Pressurized Metered-dose Inhaler Market Value Comparison by Type (2024-2030)
1.2.2 Single-dose Inhalers
1.2.3 Multi-dose Inhalers
1.3 Pressurized Metered-dose Inhaler Segment by Application
1.3.1 Global Pressurized Metered-dose Inhaler Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centres
1.4 Global Pressurized Metered-dose Inhaler Market Size Estimates and Forecasts
1.4.1 Global Pressurized Metered-dose Inhaler Revenue 2019-2030
1.4.2 Global Pressurized Metered-dose Inhaler Sales 2019-2030
1.4.3 Global Pressurized Metered-dose Inhaler Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pressurized Metered-dose Inhaler Market Competition by Manufacturers
2.1 Global Pressurized Metered-dose Inhaler Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pressurized Metered-dose Inhaler Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pressurized Metered-dose Inhaler Average Price by Manufacturers (2019-2024)
2.4 Global Pressurized Metered-dose Inhaler Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pressurized Metered-dose Inhaler, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pressurized Metered-dose Inhaler, Product Type & Application
2.7 Pressurized Metered-dose Inhaler Market Competitive Situation and Trends
2.7.1 Pressurized Metered-dose Inhaler Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pressurized Metered-dose Inhaler Players Market Share by Revenue
2.7.3 Global Pressurized Metered-dose Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pressurized Metered-dose Inhaler Retrospective Market Scenario by Region
3.1 Global Pressurized Metered-dose Inhaler Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pressurized Metered-dose Inhaler Global Pressurized Metered-dose Inhaler Sales by Region: 2019-2030
3.2.1 Global Pressurized Metered-dose Inhaler Sales by Region: 2019-2024
3.2.2 Global Pressurized Metered-dose Inhaler Sales by Region: 2025-2030
3.3 Global Pressurized Metered-dose Inhaler Global Pressurized Metered-dose Inhaler Revenue by Region: 2019-2030
3.3.1 Global Pressurized Metered-dose Inhaler Revenue by Region: 2019-2024
3.3.2 Global Pressurized Metered-dose Inhaler Revenue by Region: 2025-2030
3.4 North America Pressurized Metered-dose Inhaler Market Facts & Figures by Country
3.4.1 North America Pressurized Metered-dose Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pressurized Metered-dose Inhaler Sales by Country (2019-2030)
3.4.3 North America Pressurized Metered-dose Inhaler Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pressurized Metered-dose Inhaler Market Facts & Figures by Country
3.5.1 Europe Pressurized Metered-dose Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pressurized Metered-dose Inhaler Sales by Country (2019-2030)
3.5.3 Europe Pressurized Metered-dose Inhaler Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pressurized Metered-dose Inhaler Market Facts & Figures by Country
3.6.1 Asia Pacific Pressurized Metered-dose Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pressurized Metered-dose Inhaler Sales by Country (2019-2030)
3.6.3 Asia Pacific Pressurized Metered-dose Inhaler Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pressurized Metered-dose Inhaler Market Facts & Figures by Country
3.7.1 Latin America Pressurized Metered-dose Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pressurized Metered-dose Inhaler Sales by Country (2019-2030)
3.7.3 Latin America Pressurized Metered-dose Inhaler Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pressurized Metered-dose Inhaler Market Facts & Figures by Country
3.8.1 Middle East and Africa Pressurized Metered-dose Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pressurized Metered-dose Inhaler Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pressurized Metered-dose Inhaler Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pressurized Metered-dose Inhaler Sales by Type (2019-2030)
4.1.1 Global Pressurized Metered-dose Inhaler Sales by Type (2019-2024)
4.1.2 Global Pressurized Metered-dose Inhaler Sales by Type (2025-2030)
4.1.3 Global Pressurized Metered-dose Inhaler Sales Market Share by Type (2019-2030)
4.2 Global Pressurized Metered-dose Inhaler Revenue by Type (2019-2030)
4.2.1 Global Pressurized Metered-dose Inhaler Revenue by Type (2019-2024)
4.2.2 Global Pressurized Metered-dose Inhaler Revenue by Type (2025-2030)
4.2.3 Global Pressurized Metered-dose Inhaler Revenue Market Share by Type (2019-2030)
4.3 Global Pressurized Metered-dose Inhaler Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pressurized Metered-dose Inhaler Sales by Application (2019-2030)
5.1.1 Global Pressurized Metered-dose Inhaler Sales by Application (2019-2024)
5.1.2 Global Pressurized Metered-dose Inhaler Sales by Application (2025-2030)
5.1.3 Global Pressurized Metered-dose Inhaler Sales Market Share by Application (2019-2030)
5.2 Global Pressurized Metered-dose Inhaler Revenue by Application (2019-2030)
5.2.1 Global Pressurized Metered-dose Inhaler Revenue by Application (2019-2024)
5.2.2 Global Pressurized Metered-dose Inhaler Revenue by Application (2025-2030)
5.2.3 Global Pressurized Metered-dose Inhaler Revenue Market Share by Application (2019-2030)
5.3 Global Pressurized Metered-dose Inhaler Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Glenmark Pharmaceuticals(India)
6.1.1 Glenmark Pharmaceuticals(India) Corporation Information
6.1.2 Glenmark Pharmaceuticals(India) Description and Business Overview
6.1.3 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Product Portfolio
6.1.5 Glenmark Pharmaceuticals(India) Recent Developments/Updates
6.2 Novartis International AG(Switzerland)
6.2.1 Novartis International AG(Switzerland) Corporation Information
6.2.2 Novartis International AG(Switzerland) Description and Business Overview
6.2.3 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Product Portfolio
6.2.5 Novartis International AG(Switzerland) Recent Developments/Updates
6.3 Propeller Health(USA)
6.3.1 Propeller Health(USA) Corporation Information
6.3.2 Propeller Health(USA) Description and Business Overview
6.3.3 Propeller Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Propeller Health(USA) Pressurized Metered-dose Inhaler Product Portfolio
6.3.5 Propeller Health(USA) Recent Developments/Updates
6.4 AstraZeneca Plc(Sweden)
6.4.1 AstraZeneca Plc(Sweden) Corporation Information
6.4.2 AstraZeneca Plc(Sweden) Description and Business Overview
6.4.3 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Product Portfolio
6.4.5 AstraZeneca Plc(Sweden) Recent Developments/Updates
6.5 Philips Respironics(Netherlands)
6.5.1 Philips Respironics(Netherlands) Corporation Information
6.5.2 Philips Respironics(Netherlands) Description and Business Overview
6.5.3 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Product Portfolio
6.5.5 Philips Respironics(Netherlands) Recent Developments/Updates
6.6 Teva Pharmaceutical Industries(Israel)
6.6.1 Teva Pharmaceutical Industries(Israel) Corporation Information
6.6.2 Teva Pharmaceutical Industries(Israel) Description and Business Overview
6.6.3 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Product Portfolio
6.6.5 Teva Pharmaceutical Industries(Israel) Recent Developments/Updates
6.7 Opko Health(USA)
6.6.1 Opko Health(USA) Corporation Information
6.6.2 Opko Health(USA) Description and Business Overview
6.6.3 Opko Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Opko Health(USA) Pressurized Metered-dose Inhaler Product Portfolio
6.7.5 Opko Health(USA) Recent Developments/Updates
6.8 Merck(USA)
6.8.1 Merck(USA) Corporation Information
6.8.2 Merck(USA) Description and Business Overview
6.8.3 Merck(USA) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck(USA) Pressurized Metered-dose Inhaler Product Portfolio
6.8.5 Merck(USA) Recent Developments/Updates
6.9 BioCare Group(Malaysia)
6.9.1 BioCare Group(Malaysia) Corporation Information
6.9.2 BioCare Group(Malaysia) Description and Business Overview
6.9.3 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Product Portfolio
6.9.5 BioCare Group(Malaysia) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pressurized Metered-dose Inhaler Industry Chain Analysis
7.2 Pressurized Metered-dose Inhaler Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pressurized Metered-dose Inhaler Production Mode & Process
7.4 Pressurized Metered-dose Inhaler Sales and Marketing
7.4.1 Pressurized Metered-dose Inhaler Sales Channels
7.4.2 Pressurized Metered-dose Inhaler Distributors
7.5 Pressurized Metered-dose Inhaler Customers
8 Pressurized Metered-dose Inhaler Market Dynamics
8.1 Pressurized Metered-dose Inhaler Industry Trends
8.2 Pressurized Metered-dose Inhaler Market Drivers
8.3 Pressurized Metered-dose Inhaler Market Challenges
8.4 Pressurized Metered-dose Inhaler Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pressurized Metered-dose Inhaler Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pressurized Metered-dose Inhaler Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pressurized Metered-dose Inhaler Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pressurized Metered-dose Inhaler Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Pressurized Metered-dose Inhaler Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pressurized Metered-dose Inhaler Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pressurized Metered-dose Inhaler Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pressurized Metered-dose Inhaler, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pressurized Metered-dose Inhaler, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pressurized Metered-dose Inhaler, Product Type & Application
Table 12. Global Key Manufacturers of Pressurized Metered-dose Inhaler, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pressurized Metered-dose Inhaler by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pressurized Metered-dose Inhaler as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pressurized Metered-dose Inhaler Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pressurized Metered-dose Inhaler Sales by Region (2019-2024) & (Units)
Table 18. Global Pressurized Metered-dose Inhaler Sales Market Share by Region (2019-2024)
Table 19. Global Pressurized Metered-dose Inhaler Sales by Region (2025-2030) & (Units)
Table 20. Global Pressurized Metered-dose Inhaler Sales Market Share by Region (2025-2030)
Table 21. Global Pressurized Metered-dose Inhaler Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pressurized Metered-dose Inhaler Revenue Market Share by Region (2019-2024)
Table 23. Global Pressurized Metered-dose Inhaler Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pressurized Metered-dose Inhaler Revenue Market Share by Region (2025-2030)
Table 25. North America Pressurized Metered-dose Inhaler Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pressurized Metered-dose Inhaler Sales by Country (2019-2024) & (Units)
Table 27. North America Pressurized Metered-dose Inhaler Sales by Country (2025-2030) & (Units)
Table 28. North America Pressurized Metered-dose Inhaler Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pressurized Metered-dose Inhaler Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pressurized Metered-dose Inhaler Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pressurized Metered-dose Inhaler Sales by Country (2019-2024) & (Units)
Table 32. Europe Pressurized Metered-dose Inhaler Sales by Country (2025-2030) & (Units)
Table 33. Europe Pressurized Metered-dose Inhaler Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pressurized Metered-dose Inhaler Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pressurized Metered-dose Inhaler Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pressurized Metered-dose Inhaler Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Pressurized Metered-dose Inhaler Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Pressurized Metered-dose Inhaler Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pressurized Metered-dose Inhaler Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pressurized Metered-dose Inhaler Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pressurized Metered-dose Inhaler Sales by Country (2019-2024) & (Units)
Table 42. Latin America Pressurized Metered-dose Inhaler Sales by Country (2025-2030) & (Units)
Table 43. Latin America Pressurized Metered-dose Inhaler Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pressurized Metered-dose Inhaler Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pressurized Metered-dose Inhaler Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pressurized Metered-dose Inhaler Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa Pressurized Metered-dose Inhaler Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa Pressurized Metered-dose Inhaler Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pressurized Metered-dose Inhaler Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pressurized Metered-dose Inhaler Sales (Units) by Type (2019-2024)
Table 51. Global Pressurized Metered-dose Inhaler Sales (Units) by Type (2025-2030)
Table 52. Global Pressurized Metered-dose Inhaler Sales Market Share by Type (2019-2024)
Table 53. Global Pressurized Metered-dose Inhaler Sales Market Share by Type (2025-2030)
Table 54. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pressurized Metered-dose Inhaler Revenue Market Share by Type (2019-2024)
Table 57. Global Pressurized Metered-dose Inhaler Revenue Market Share by Type (2025-2030)
Table 58. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Type (2019-2024)
Table 59. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Type (2025-2030)
Table 60. Global Pressurized Metered-dose Inhaler Sales (Units) by Application (2019-2024)
Table 61. Global Pressurized Metered-dose Inhaler Sales (Units) by Application (2025-2030)
Table 62. Global Pressurized Metered-dose Inhaler Sales Market Share by Application (2019-2024)
Table 63. Global Pressurized Metered-dose Inhaler Sales Market Share by Application (2025-2030)
Table 64. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pressurized Metered-dose Inhaler Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pressurized Metered-dose Inhaler Revenue Market Share by Application (2019-2024)
Table 67. Global Pressurized Metered-dose Inhaler Revenue Market Share by Application (2025-2030)
Table 68. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Application (2019-2024)
Table 69. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Application (2025-2030)
Table 70. Glenmark Pharmaceuticals(India) Corporation Information
Table 71. Glenmark Pharmaceuticals(India) Description and Business Overview
Table 72. Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Product
Table 74. Glenmark Pharmaceuticals(India) Recent Developments/Updates
Table 75. Novartis International AG(Switzerland) Corporation Information
Table 76. Novartis International AG(Switzerland) Description and Business Overview
Table 77. Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Product
Table 79. Novartis International AG(Switzerland) Recent Developments/Updates
Table 80. Propeller Health(USA) Corporation Information
Table 81. Propeller Health(USA) Description and Business Overview
Table 82. Propeller Health(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Propeller Health(USA) Pressurized Metered-dose Inhaler Product
Table 84. Propeller Health(USA) Recent Developments/Updates
Table 85. AstraZeneca Plc(Sweden) Corporation Information
Table 86. AstraZeneca Plc(Sweden) Description and Business Overview
Table 87. AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Product
Table 89. AstraZeneca Plc(Sweden) Recent Developments/Updates
Table 90. Philips Respironics(Netherlands) Corporation Information
Table 91. Philips Respironics(Netherlands) Description and Business Overview
Table 92. Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Product
Table 94. Philips Respironics(Netherlands) Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries(Israel) Corporation Information
Table 96. Teva Pharmaceutical Industries(Israel) Description and Business Overview
Table 97. Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Product
Table 99. Teva Pharmaceutical Industries(Israel) Recent Developments/Updates
Table 100. Opko Health(USA) Corporation Information
Table 101. Opko Health(USA) Description and Business Overview
Table 102. Opko Health(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Opko Health(USA) Pressurized Metered-dose Inhaler Product
Table 104. Opko Health(USA) Recent Developments/Updates
Table 105. Merck(USA) Corporation Information
Table 106. Merck(USA) Description and Business Overview
Table 107. Merck(USA) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Merck(USA) Pressurized Metered-dose Inhaler Product
Table 109. Merck(USA) Recent Developments/Updates
Table 110. BioCare Group(Malaysia) Corporation Information
Table 111. BioCare Group(Malaysia) Description and Business Overview
Table 112. BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Product
Table 114. BioCare Group(Malaysia) Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Pressurized Metered-dose Inhaler Distributors List
Table 118. Pressurized Metered-dose Inhaler Customers List
Table 119. Pressurized Metered-dose Inhaler Market Trends
Table 120. Pressurized Metered-dose Inhaler Market Drivers
Table 121. Pressurized Metered-dose Inhaler Market Challenges
Table 122. Pressurized Metered-dose Inhaler Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pressurized Metered-dose Inhaler
Figure 2. Global Pressurized Metered-dose Inhaler Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pressurized Metered-dose Inhaler Market Share by Type in 2023 & 2030
Figure 4. Single-dose Inhalers Product Picture
Figure 5. Multi-dose Inhalers Product Picture
Figure 6. Global Pressurized Metered-dose Inhaler Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pressurized Metered-dose Inhaler Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Ambulatory Surgery Centres
Figure 10. Global Pressurized Metered-dose Inhaler Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pressurized Metered-dose Inhaler Market Size (2019-2030) & (US$ Million)
Figure 12. Global Pressurized Metered-dose Inhaler Sales (2019-2030) & (Units)
Figure 13. Global Pressurized Metered-dose Inhaler Average Price (USD/Unit) & (2019-2030)
Figure 14. Pressurized Metered-dose Inhaler Report Years Considered
Figure 15. Pressurized Metered-dose Inhaler Sales Share by Manufacturers in 2023
Figure 16. Global Pressurized Metered-dose Inhaler Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Pressurized Metered-dose Inhaler Players: Market Share by Revenue in 2023
Figure 18. Pressurized Metered-dose Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Pressurized Metered-dose Inhaler Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Pressurized Metered-dose Inhaler Sales Market Share by Country (2019-2030)
Figure 21. North America Pressurized Metered-dose Inhaler Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Pressurized Metered-dose Inhaler Sales Market Share by Country (2019-2030)
Figure 25. Europe Pressurized Metered-dose Inhaler Revenue Market Share by Country (2019-2030)
Figure 26. Germany Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pressurized Metered-dose Inhaler Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Pressurized Metered-dose Inhaler Revenue Market Share by Region (2019-2030)
Figure 33. China Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Pressurized Metered-dose Inhaler Sales Market Share by Country (2019-2030)
Figure 44. Latin America Pressurized Metered-dose Inhaler Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Pressurized Metered-dose Inhaler Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Pressurized Metered-dose Inhaler Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Pressurized Metered-dose Inhaler Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Pressurized Metered-dose Inhaler by Type (2019-2030)
Figure 54. Global Revenue Market Share of Pressurized Metered-dose Inhaler by Type (2019-2030)
Figure 55. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Pressurized Metered-dose Inhaler by Application (2019-2030)
Figure 57. Global Revenue Market Share of Pressurized Metered-dose Inhaler by Application (2019-2030)
Figure 58. Global Pressurized Metered-dose Inhaler Price (USD/Unit) by Application (2019-2030)
Figure 59. Pressurized Metered-dose Inhaler Value Chain
Figure 60. Pressurized Metered-dose Inhaler Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
